Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check3 days agoChange DetectedThe NCT00553631 record is now displayed with details of the completed Phase 3 Gaucher disease trial, including its treatment comparison, participant criteria, study measures, and locations.SummaryDifference54%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide NIH notice appears above the page, linking to updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the access-denied page.SummaryDifference0.3%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.3%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error rather than the study content, with navigation and footer visible. This indicates the study record is currently inaccessible.SummaryDifference18%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.